Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition.

[1]  M. Beal,et al.  Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model , 2009, Neurobiology of Aging.

[2]  M. Beal,et al.  Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  L. Placanica,et al.  Gender- and Age-Dependent γ-Secretase Activity in Mouse Brain and Its Implication in Sporadic Alzheimer Disease , 2009, PloS one.

[4]  M. Sporn,et al.  Triterpenoid CDDO‐methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer’s disease , 2009, Journal of neurochemistry.

[5]  D. Butterfield,et al.  Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age. , 2008, Free radical biology & medicine.

[6]  Y. Matsuo,et al.  Amyloid Oligomer Conformation in a Group of Natively Folded Proteins , 2008, PloS one.

[7]  Paul S. Aisen,et al.  Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model , 2008, Brain Research.

[8]  P. Axelsen,et al.  Promotion of amyloid beta protein misfolding and fibrillogenesis by a lipid oxidation product. , 2008, Journal of molecular biology.

[9]  C. Masters,et al.  Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau , 2007, PloS one.

[10]  D. Butterfield,et al.  Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: Implications for the role of nitration in the progression of Alzheimer's disease , 2007, Brain Research.

[11]  W. Klein,et al.  Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine* , 2007, Journal of Biological Chemistry.

[12]  C. Xiong,et al.  Gender differences in free radical homeostasis during aging: shorter‐lived female C57BL6 mice have increased oxidative stress , 2006, Aging cell.

[13]  L. Mucke,et al.  Reduction in Mitochondrial Superoxide Dismutase Modulates Alzheimer's Disease-Like Pathology and Accelerates the Onset of Behavioral Changes in Human Amyloid Precursor Protein Transgenic Mice , 2006, The Journal of Neuroscience.

[14]  G. Higgins,et al.  Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice , 2005, Behavioural Brain Research.

[15]  G. Gibson,et al.  Reduction in the E2k Subunit of the α-Ketoglutarate Dehydrogenase Complex Has Effects Independent of Complex Activity* , 2005, Journal of Biological Chemistry.

[16]  R. Lerner,et al.  Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. , 2005, Biochemistry.

[17]  R. Butterworth,et al.  Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease , 1990, Metabolic Brain Disease.

[18]  M. Beal,et al.  The alpha-ketoglutarate-dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration. , 2005, Molecular neurobiology.

[19]  William M. Mauck,et al.  Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice , 2004, Journal of neurochemistry.

[20]  M. Duchen,et al.  Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress. , 2004, Neurochemical research.

[21]  Heikki Tanila,et al.  Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice , 2003, Neurobiology of Disease.

[22]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[23]  D. Butterfield,et al.  Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress , 2002 .

[24]  D. Butterfield,et al.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. , 2001, Trends in molecular medicine.

[25]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[26]  S. Turner,et al.  Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695* , 2001, The Journal of Biological Chemistry.

[27]  Virginia M. Y. Lee,et al.  Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis , 2001, The Journal of Neuroscience.

[28]  D. Butterfield,et al.  Methionine residue 35 is important in amyloid β-peptide-associated free radical oxidative stress , 1999, Brain Research Bulletin.

[29]  Xudong Huang,et al.  The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.

[30]  G E Gibson,et al.  α‐ketoglutarate dehydrogenase in alzheimer brains bearing the APP670/671 mutation , 1998 .

[31]  M. Tabaton,et al.  Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.

[32]  Y. Ando,et al.  Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid , 1998, Journal of the Neurological Sciences.

[33]  J. B. Hutchins,et al.  Mitochondrial Manganese Superoxide Dismutase Prevents Neural Apoptosis and Reduces Ischemic Brain Injury: Suppression of Peroxynitrite Production, Lipid Peroxidation, and Mitochondrial Dysfunction , 1998, The Journal of Neuroscience.

[34]  Mark A. Smith,et al.  4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.

[35]  Joseph S. Beckman,et al.  Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.

[36]  S. Kish,et al.  Brain α‐Ketoglutarate Dehydrotenase Complex Activity in Alzheimer's Disease , 1993 .

[37]  S. Kish,et al.  Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. , 1993, Journal of neurochemistry.

[38]  J. Blass,et al.  Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. , 1988, Archives of neurology.